U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
PROTEIN C
3Z6S89TXPW
US Approved Rx (2013)
First approved in 2007
General
Record Details
Variant Concepts
1
Names
6
Classification
15
Identifiers
11
Subunits
1
Glycosylation
4
Relationships
1
Active Moiety
1
Characteristic Attributes
2
PROTEIN C
3Z6S89TXPW
US Approved Rx (2013)
First approved in 2007
General
Approval Year
2007
205
Record Details
Substance Class
Protein
Protein Type
COAGULATION FACTOR
Protein Sub Type
Sequence Origin
HUMAN
Sequence Type
COMPLETE
Record UNII
3Z6S89TXPW
Record Status
Validated (UNII)
Record Version
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Show
5
20
100
All
entries
Related Record
Type
Related Record
Type
No data available in table
Showing 0 to 0 of 0 entries
Previous
Next
Names
6
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
PROTEIN C
Common Name
English
PROTEIN C [EMA EPAR]
Common Name
English
PROTEIN C (HOMO SAPIENS)
Common Name
English
Protein c (coagulation inhibitor) [WHO-DD]
Common Name
English
PROTEIN C HUMAN
Common Name
English
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Classification
15
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Reversal of anticoagulation therapy in patients needing treatment of serious or life threatening bleeding and/or needing urgent surgery or invasive procedures
FDA ORPHAN DRUG
225806
Designated/Approved
ORPHAN DRUG
Designated/Approved
For replacement therapy in congenital protein C deficiency for the prevention and treatment of thrombosis, pulmonary emboli, and purpura fulminans.
FDA ORPHAN DRUG
65392
PPP
LOINC
ACTIVE
COAG
PPP
Protein C/Coagulation factor IX
[Mass Ratio] in Platelet poor plasma
LOINC
13050-0
Agent Affecting Blood or Body Fluid
Pharmacologic Substance
[C1909]
Agent Affecting Blood or Body Fluid
[C78275]
Anticoagulant Agent
NCI_THESAURUS
C263
PPP
LOINC
ACTIVE
COAG
PPP
Protein C+Acarboxy Ag
[Units/volume] in Platelet poor plasma by Immunoassay
LOINC
6008-7
Showing 1 to 5 of 15 entries
Previous
1
2
3
Next
Identifiers
11
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
NDF-RT
N0000168402
PRIMARY
Enzyme Precursors [Chemical/Ingredient]
NDF-RT
N0000008556
PRIMARY
Decreased Coagulation Factor Activity [PE]
DAILYMED
3Z6S89TXPW
PRIMARY
MESH
D011486
PRIMARY
DRUG BANK
DB11312
PRIMARY
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Subunits
1
Subunit 0
>SUBUNIT_0
Glycosylation
4
Glycosylation Type
MAMMALIAN
Show
5
20
100
All
entries
Glycosylation Link Type
Site
Glycosylation Link Type
Site
N
1_139
N
1_290
N
1_355
N
1_371
Showing 1 to 4 of 4 entries
Previous
1
Next
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
PROTEIN C CONCENTRATE (HUMAN)
SUB_CONCEPT->SUBSTANCE
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
3Z6S89TXPW
PROTEIN C
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Molecular Formula
CHEMICAL
ESTIMATED
C2240H3473N638O650S32
MOL_WEIGHT:FORMULA
CHEMICAL
FORMULA 51940 Da (average)
Showing 1 to 2 of 2 entries
Previous
1
Next
